Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 865053, 6 pages
http://dx.doi.org/10.1155/2015/865053
Research Article

Allelic Imbalance of mRNA Associated with α2-HS Glycoprotein (Fetuin-A) Polymorphism

Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan

Received 25 June 2015; Accepted 20 September 2015

Academic Editor: Ralf Lichtinghagen

Copyright © 2015 Yoshihiko Inaoka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C.-C. Lee, B. H. Bowman, and F. M. Yang, “Human alpha 2-HS-glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcript,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 13, pp. 4403–4407, 1987. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Mori, M. Emoto, and M. Inaba, “Fetuin-A: a multifunctional protein,” Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, vol. 5, no. 2, pp. 124–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Auberger, L. Falquerho, J. O. Contreres et al., “Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity,” Cell, vol. 58, no. 4, pp. 631–640, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. A.-S. Goustin and A. B. Abou-Samra, “The ‘thrifty’ gene encoding Ahsg/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance,” Cellular Signalling, vol. 23, no. 6, pp. 980–990, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Pal, S. Dasgupta, R. Kundu et al., “Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance,” Nature Medicine, vol. 18, no. 8, pp. 1279–1285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Dahlman, P. Eriksson, M. Kaaman et al., “α2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action,” Diabetologia, vol. 47, no. 11, pp. 1974–1979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Vetter, L. W. Fisher, K. P. Mintz et al., “Osteogenesis imperfecta: changes in noncollagenous proteins in bone,” Journal of Bone and Mineral Research, vol. 6, no. 5, pp. 501–505, 1991. View at Google Scholar · View at Scopus
  8. A. Heiss, A. DuChesne, B. Denecke et al., “Structural basis of calcification inhibition by α2-HS glycoprotein/fetuin-A: formation of colloidal calciprotein particles,” The Journal of Biological Chemistry, vol. 278, no. 15, pp. 13333–13341, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ketteler, P. Bongartz, R. Westenfeld et al., “Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study,” The Lancet, vol. 361, no. 9360, pp. 827–833, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. W. Cox, B. J. Andrews, and D. E. Wills, “Genetic polymorphism of α2HS-glycoprotein,” American Journal of Human Genetics, vol. 38, no. 5, pp. 699–706, 1986. View at Google Scholar · View at Scopus
  11. M. Osawa, K. Umetsu, T. Ohki, T. Nagasawa, T. Suzuki, and S. Takeichi, “Molecular evidence for human alpha2-HS glycoprotein (AHSG) polymorphism,” Human Genetics, vol. 99, no. 1, pp. 18–21, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Osawa, W. Tian, H. Horiuchi, M. Kaneko, and K. Umetsu, “Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels,” Human Genetics, vol. 116, no. 3, pp. 146–151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Lavebratt, S. Wahlqvist, L. Nordfors, J. Hoffstedt, and P. Arner, “AHSG gene variant is associated with leanness among Swedish men,” Human Genetics, vol. 117, no. 1, pp. 54–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. K. Jensen, T. M. Bartz, L. Djousse et al., “Genetically elevated fetuin- A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study,” Diabetes Care, vol. 36, no. 10, pp. 3121–3127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Inoue, H. Takata, Y. Ikeda et al., “A promoter polymorphism of the α2-HS glycoprotein gene is associated with its transcriptional activity,” Diabetes Research and Clinical Practice, vol. 79, no. 1, pp. 164–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Siddiq, F. Lepretre, S. Hercberg, P. Froguel, and F. Gibson, “A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians,” Diabetes, vol. 54, no. 8, pp. 2477–2481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. MacKenzie, B. Hing, and S. Davidson, “Exploring the effects of polymorphisms on cis-regulatory signal transduction response,” Trends in Molecular Medicine, vol. 19, no. 2, pp. 99–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Jahnen-Dechent, A. Trindl, J. Godovac-Zimmermann, and W. Muller-Esterl, “Posttranslational processing of human α2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells,” European Journal of Biochemistry, vol. 226, no. 1, pp. 59–69, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. P. R. Buckland, “Allele-specific gene expression differences in humans,” Human Molecular Genetics, vol. 13, no. 2, pp. R255–R260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Tamura, M. Osawa, R. Kimura et al., “Evaluation of the allele-sharing approach, known as the IBS method, in kinship analysis,” Journal of Forensic and Legal Medicine, vol. 20, no. 2, pp. 112–116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Eichner, C. A. Friedrich, J. A. Cauley et al., “Alpha2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women,” Calcified Tissue International, vol. 47, no. 6, pp. 345–349, 1990. View at Publisher · View at Google Scholar
  22. C. Sritara, A. Thakkinstian, B. Ongphiphadhanakul et al., “Causal relationship between the AHSG gene and BMD through fetuin-A and BMI: multiple mediation analysis,” Osteoporosis International, vol. 25, no. 5, pp. 1555–1562, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Mori, M. Emoto, T. Araki et al., “Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus,” Metabolism: Clinical and Experimental, vol. 57, no. 9, pp. 1248–1252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Andersen, K. S. Burgdorf, T. Sparsø et al., “AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white danish subjects,” Diabetes, vol. 57, no. 5, pp. 1427–1432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Temesszentandrási, K. Vörös, Z. Böröcz et al., “Association of human fetuin-A rs4917 polymorphism with obesity in 2 cohorts,” Journal of Investigative Medicine, vol. 63, no. 3, pp. 548–553, 2015. View at Publisher · View at Google Scholar
  26. P. Stenvinkel, K. Wang, A. R. Qureshi et al., “Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin,” Kidney International, vol. 67, no. 6, pp. 2383–2392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Fisher, N. Stefan, K. Saar et al., “Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-potsdam study,” Circulation: Cardiovascular Genetics, vol. 2, no. 6, pp. 607–613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Ma, Z. He, J. Zhao et al., “Association of AHSG gene polymorphisms with ischemic stroke in a Han Chinese population,” Biochemical Genetics, vol. 51, no. 11-12, pp. 916–926, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. V. Rockman and G. A. Wray, “Abundant raw material for cis-regulatory evolution in humans,” Molecular Biology and Evolution, vol. 19, no. 11, pp. 1991–2004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. R. Tollervey, T. Curk, B. Rogelj et al., “Characterizing the RNA targets and position-dependent splicing regulation by TDP-43,” Nature Neuroscience, vol. 14, no. 4, pp. 452–458, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Kameyama, H. Suzuki, and A. Mayeda, “Re-splicing of mature mRNA in cancer cells promotes activation of distant weak alternative splice sites,” Nucleic Acids Research, vol. 40, no. 16, pp. 7896–7906, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Osawa, I. Yuasa, T. Kitano et al., “Haplotype analysis of the human alpha2-HS glycoprotein (fetuin) gene,” Annals of Human Genetics, vol. 65, part 1, pp. 27–34, 2001. View at Google Scholar